Polycythemia as a Complication of Testosterone Replacement Therapy in Nursing Home Men with Low Testosterone Levels

Polycythemia as a Complication of Testosterone Replacement Therapy in Nursing Home Men with Low... P revious investigators have reported that erythrocytosis or polycythemia may be a complication of testosterone replacement therapy. Hematocrit elevation may be associated with increased blood viscosity, stagnant flow, and vascular occlusion. 1 This complication is not widely recognized and, therefore, hematocrit monitoring during testosterone replacement is not standard practice in some medical centers. Factors predisposing to the development of erythrocytosis have not been defined. We report reversible polycythemia in hypogonadal nursing home men with risk factors for the sleep apnea syndrome who were participating in a clinical trial of the effects of testosterone replacement on bone density. METHODS AND PROCEDURES The study was conducted in long‐term care residents at the Zablocki Veterans Administration Medical Center in Milwaukee, Wisconsin and the Wisconsin Veterans Home at King. Twenty‐six competent male veterans aged 60 to 90 having two morning total testosterone values with a mean less than 320 mg/100 cc and free testosterone values less than 12 pg/mL, body weight between 90 and 130% of ideal, and normal UA, CBC, and chemistry panel were recruited. Men with connective tissue diseases, inflammatory bowel disease, chronic urinary tract infection, cardiomegaly, uncontrolled hypertension, elevated PSA values, or abnormalities on digital rectal exam or transrectal http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of American Geriatrics Society Wiley

Polycythemia as a Complication of Testosterone Replacement Therapy in Nursing Home Men with Low Testosterone Levels

Loading next page...
 
/lp/wiley/polycythemia-as-a-complication-of-testosterone-replacement-therapy-in-Vl1fyMgPn5
Publisher
Wiley
Copyright
1995 The American Geriatrics Society
ISSN
0002-8614
eISSN
1532-5415
DOI
10.1111/j.1532-5415.1995.tb05534.x
Publisher site
See Article on Publisher Site

Abstract

P revious investigators have reported that erythrocytosis or polycythemia may be a complication of testosterone replacement therapy. Hematocrit elevation may be associated with increased blood viscosity, stagnant flow, and vascular occlusion. 1 This complication is not widely recognized and, therefore, hematocrit monitoring during testosterone replacement is not standard practice in some medical centers. Factors predisposing to the development of erythrocytosis have not been defined. We report reversible polycythemia in hypogonadal nursing home men with risk factors for the sleep apnea syndrome who were participating in a clinical trial of the effects of testosterone replacement on bone density. METHODS AND PROCEDURES The study was conducted in long‐term care residents at the Zablocki Veterans Administration Medical Center in Milwaukee, Wisconsin and the Wisconsin Veterans Home at King. Twenty‐six competent male veterans aged 60 to 90 having two morning total testosterone values with a mean less than 320 mg/100 cc and free testosterone values less than 12 pg/mL, body weight between 90 and 130% of ideal, and normal UA, CBC, and chemistry panel were recruited. Men with connective tissue diseases, inflammatory bowel disease, chronic urinary tract infection, cardiomegaly, uncontrolled hypertension, elevated PSA values, or abnormalities on digital rectal exam or transrectal

Journal

Journal of American Geriatrics SocietyWiley

Published: Aug 1, 1995

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off